{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/pityriasis-versicolor/how-up-to-date-is-this-topic/changes/","result":{"pageContext":{"chapter":{"id":"fd8be5be-8d54-5431-88b3-44c33e4401da","slug":"changes","fullItemName":"Changes","depth":2,"htmlHeader":"<!-- begin field fba8e382-b607-43e1-9cc1-4c7e45e1ec20 --><h2>Changes</h2><!-- end field fba8e382-b607-43e1-9cc1-4c7e45e1ec20 -->","summary":null,"htmlStringContent":"<!-- begin item 2a8306a2-659e-40da-badc-a2d95808cd6d --><!-- begin field 4fe3e3b4-755e-4981-921c-a578a112371a --><p><strong>March to April 2020 </strong>— reviewed. A literature search was conducted in February 2020 to identify evidence-based guidelines, UK policy, systematic reviews, and key randomized controlled trials published since the last revision of the topic. No major changes to clinical recommendations have been made.</p><!-- end field 4fe3e3b4-755e-4981-921c-a578a112371a --><!-- end item 2a8306a2-659e-40da-badc-a2d95808cd6d -->","topic":{"id":"0fea6769-8496-527e-9900-49c0411410df","topicId":"c13665df-bfcd-4fcc-b476-7e462353856b","topicName":"Pityriasis versicolor","slug":"pityriasis-versicolor","lastRevised":"Last revised in April 2020","chapters":[{"id":"48061d3b-77de-5625-838f-3490efd16385","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"a2b64334-2f3e-5682-a55c-d89347f8b48f","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"ce5bd4c2-7fa7-58e8-83bd-614d945b9710","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"fd8be5be-8d54-5431-88b3-44c33e4401da","slug":"changes","fullItemName":"Changes"},{"id":"fc8f8e10-88b6-5879-a69c-18f87f3c8340","slug":"update","fullItemName":"Update"}]},{"id":"ef705ed5-a47f-528d-97cc-8d9af2963eb5","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"5fdd92bc-0340-527b-8689-d48f307ce6e3","slug":"goals","fullItemName":"Goals"},{"id":"ec48d89c-955c-5e3d-af73-6e587354a56d","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"ecafa7cb-70ed-551b-b6d1-ddcf4f6bed3d","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"fd61e511-1bf0-541e-8192-19970ba59e82","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"05312c95-9379-5709-872d-b3e10aebfcc0","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"b5911b4a-ad4b-52c9-9bfe-a0978bdc63c5","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"08f0e975-952b-5ec7-a211-0f0a447d63b6","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"d63e7392-070c-56c9-890f-bc58ae7b5b3a","slug":"definition","fullItemName":"Definition"},{"id":"1fbe5c19-2ec5-50c3-b69f-a251b7bfbd1c","slug":"causes","fullItemName":"Causes"},{"id":"2e638f9d-1d65-5294-9020-379452470ca9","slug":"prevalence","fullItemName":"Prevalence"},{"id":"c223ff1b-62e0-5bc5-bb16-aee1037798a3","slug":"prognosis","fullItemName":"Prognosis"},{"id":"7e95bc3b-7443-5b1f-aa77-97a44859c0ee","slug":"complications","fullItemName":"Complications"}]},{"id":"5a3a3c2c-acb7-5f56-af38-2ddbcc543c8f","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"e5b4b862-ed72-5b87-88c3-cec73356d952","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"c0059764-1025-5915-ae2c-8a71310be239","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"9c584d50-0808-57d6-b5c7-cb1af47c1be2","fullItemName":"Management","slug":"management","subChapters":[{"id":"216757cf-4ca3-5974-b742-43171690f9df","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"05482fa5-1c4b-5f1b-8b8e-6137e274e4e5","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"d7f1cba7-9069-572c-b52d-d9319951ed08","slug":"ketoconazole-2percent-shampoo","fullItemName":"Ketoconazole 2% shampoo"},{"id":"54569984-7427-54f7-b6cb-3522c344a0de","slug":"topical-imidazole-creams","fullItemName":"Topical imidazole creams"},{"id":"11062d95-1795-54d5-88e9-9c9d1464555e","slug":"selenium-sulphide-shampoo","fullItemName":"Selenium sulphide shampoo"},{"id":"ff895dc9-00a2-59b2-9e11-6529379ea8fd","slug":"oral-fluconazole","fullItemName":"Oral fluconazole"},{"id":"95b98848-e241-56a6-b83d-380420c23440","slug":"oral-itraconazole","fullItemName":"Oral itraconazole"}]},{"id":"9d664332-8ca1-5c9d-a030-544c2adfea31","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"5609556e-dbb4-56de-8035-bced2df7d533","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"8e7f4e16-d4b6-59d4-919a-6eb3a9f60a94","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"a652af6c-c591-5583-ba4e-0ce6cb952e3b","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"e7e76cf0-a6de-51cc-9a4b-89194241dc6d","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"d791c177-66f7-5aaa-ab09-a2079d32f854","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"12d54e36-6600-5446-83a4-05d3c235b7f0","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"f54e136f-01a7-5fed-a635-fa6f209d4e3f","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"ce5bd4c2-7fa7-58e8-83bd-614d945b9710","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?"},"subChapters":[{"id":"eef9cc4e-d03c-5e2e-ba1b-9ba60f70ac4f","slug":"previous-changes","fullItemName":"Previous changes","depth":3,"htmlHeader":"<!-- begin field dec91377-30dd-4736-85c6-5fddb6b3f857 --><h3>Previous changes</h3><!-- end field dec91377-30dd-4736-85c6-5fddb6b3f857 -->","summary":null,"htmlStringContent":"<!-- begin item a4417fe3-2eaf-42d2-b850-ce0b0fd4b626 --><!-- begin field d8bd4b77-b81b-42cd-999f-90223d062ab5 --><p><strong>November to December 2015</strong> — reviewed. A literature search was conducted in November 2015 to identify evidence-based guidelines, UK policy, systematic reviews, and key randomized controlled trials published since the last revision of the topic. No changes to clinical recommendations have been made.</p><p><strong>February 2011</strong> — minor update. Suggested regimen for preventing recurrence of pityriasis versicolor corrected to ketoconazole shampoo. Issued in February 2011.</p><p><strong>July to November 2010</strong> — this is a new CKS topic. The evidence-base has been reviewed in detail, and recommendations are clearly justified and transparently linked to the supporting evidence.</p><!-- end field d8bd4b77-b81b-42cd-999f-90223d062ab5 --><!-- end item a4417fe3-2eaf-42d2-b850-ce0b0fd4b626 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}